Novo Nordisk is no longer a buy at UBS, which says compounding is here to
stay
-
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy
drugs used for weight loss, was downgraded due to competition from
compounding as w...
37 minutes ago
No comments:
Post a Comment
social network